Baird Medical (BDMD) Fundamental Analysis: Revenue, Earnings & Valuation

0.95 / 10

Underperform

Fundamentally, BDMD is rated Underperform with a 0.9/10 score. ROA and net‑profit‑margin on assets are marginally positive, but ROE, diluted ROE and annualized ROE are deeply negative, indicating poor profitability and high risk.

Analysis Checks(2/6)

ROA (%)

Value-14.66

Score2/3

Weight-7.88%

1M Return0.63%

Annualized return on equity (%)

Value-60.04

Score1/3

Weight21.71%

1M Return-2.02%

Annualized net profit margin on total assets (%)

Value-29.32

Score2/3

Weight-7.88%

1M Return0.63%

ROE (diluted) (%)

Value-31.74

Score0/3

Weight48.11%

1M Return-5.82%

ROE (%)

Value-30.02

Score1/3

Weight21.71%

1M Return-2.02%

Net profit / Total profit (%)

Value105.18

Score1/3

Weight24.24%

1M Return-2.37%

Is BDMD fundamentally strong?

BDMD scores 0.95/10 on fundamentals and holds a Premium valuation at present. Backed by its -29.96% ROE, -9.84% net margin, -16.83 P/E ratio, 1.50 P/B ratio, and -117.74% earnings growth, these metrics solidify its Underperform investment rating.